Patents by Inventor Hasmukh Mathurbhai Patel

Hasmukh Mathurbhai Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8633241
    Abstract: The present invention provides an improved process for the synthesis of nebivolol or its pharmaceutically acceptable salts, more particularly hydrochloride salt of formula (I). The present invention further provides a new Form T1 of nebivolol and its pharmaceutically acceptable salts. The present invention also provides pharmaceutical compositions and process for the preparation of a solid oral dosage form of nebivolol hydrochloride of formula (I), without the use of wetting agent, and optionally using binder and/or disintegrant.
    Type: Grant
    Filed: April 9, 2013
    Date of Patent: January 21, 2014
    Assignee: Forest Laboratories Holdings, Limited
    Inventors: Srinivasarao Veeravenkata Attanti, Hasmukh Mathurbhai Patel, Sunil Sadanand Nadkarni
  • Patent number: 8604222
    Abstract: The present invention provides an improved process for the synthesis of nebivolol or its pharmaceutically acceptable salts, more particularly hydrochloride salt of formula (I). The present invention further provides a new Form T1 of nebivolol and its pharmaceutically acceptable salts. The present invention also provides pharmaceutical compositions and process for the preparation of a solid oral dosage form of nebivolol hydrochloride of formula (I), without the use of wetting agent, and optionally using binder and/or disintegrant.
    Type: Grant
    Filed: August 1, 2005
    Date of Patent: December 10, 2013
    Assignee: Forest Laboratories Holdings Limited
    Inventors: Rakesh Sheth, Srinivasarao Veeravenkata Attanti, Hasmukh Mathurbhai Patel, Vinodkumar Gupta, Sunil Sadanand Nadkarni
  • Publication number: 20130296583
    Abstract: The present invention provides an improved process for the synthesis of nebivolol or its pharmaceutically acceptable salts, more particularly hydrochloride salt of formula (I). The present invention further provides a new Form T1 of nebivolol and its pharmaceutically acceptable salts. The present invention also provides pharmaceutical compositions and process for the preparation of a solid oral dosage form of nebivolol hydrochloride of formula (I), without the use of wetting agent, and optionally using binder and/or disintegrant.
    Type: Application
    Filed: April 9, 2013
    Publication date: November 7, 2013
    Inventors: Rakesh Sheth, Srinivasarao Veeravenkata Attanti, Hasmukh Mathurbhai Patel, Vinodkumar Gupta, Sunil Sadanand Nadkarni
  • Publication number: 20090175935
    Abstract: The present invention relates to solid oral pharmaceutical compositions of duloxetine, process for preparing such compositions and method of using such compositions. Preferably, the invention relates to a delayed release composition of duloxetine comprising a core comprising duloxetine, optional separating coat and an enteric coat, wherein the enteric coat comprises methacrylic acid copolymer.
    Type: Application
    Filed: August 10, 2007
    Publication date: July 9, 2009
    Applicant: TORRENT RESEARCH LTD.
    Inventors: Umesh Setty, Rakesh Kiritbhai Sheth, Sujay Kamalakar Rajhans, Pravin Meghraj Bhutada, Hasmukh Mathurbhai Patel